Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;85:294-301

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engel, F. B.
Right arrow Articles by von Harsdorf, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engel, F. B.
Right arrow Articles by von Harsdorf, R.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Cell biology/structural biology
Right arrow Genomics
(Circulation Research. 1999;85:294-301.)
© 1999 American Heart Association, Inc.


Rapid Communication

A Mammalian Myocardial Cell-Free System to Study Cell Cycle Reentry in Terminally Differentiated Cardiomyocytes

Felix B. Engel, Ludger Hauck, M. Cristina Cardoso, Heinrich Leonhardt, Rainer Dietz, Rüdiger von Harsdorf

From the Department of Cardiology (F.B.E., L.H., R.D., R.v.H.), Franz Volhard Clinic, Humboldt University, and the Max Delbrück Center for Molecular Medicine (M.C.C., H.L.), Berlin, Germany.

Correspondence to Rüdiger v. Harsdorf, MD, Franz-Volhard-Klinik, Universitätsklinikum Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin, Wiltbergstr 50, 13125 Berlin, Germany. E-mail rharsdo{at}mdc-berlin.de

Abstract—Cardiomyocytes withdraw from the cell cycle in the early neonatal period, rendering the adult heart incapable to regenerate after injury. In the present study, we report the establishment of a cell-free system to investigate the control of cell cycle reentry in mammalian ventricular cardiomyocyte nuclei and to specifically address the question of whether nuclei from terminally differentiated cardiomyocytes can be stimulated to reenter S phase when incubated with extracts from S-phase cells. Immobilized cardiomyocyte nuclei were incubated with nuclei and cytoplasmic extract of synchronized H9c2 muscle cells or cardiac nonmyocytes. Ongoing DNA synthesis was monitored by biotin-16-dUTP incorporation as well as proliferating cell nuclear antigen expression and localization. Nuclei and cytoplasmic extract from S-phase H9c2 cells but not from H9c2 myotubes induced DNA synthesis in 92% of neonatal cardiomyocyte nuclei. Coincubation in the presence of cycloheximide indicated that de novo translation is required for the reinduction of S phase. Similar results were obtained with adult cardiomyocyte nuclei. When coincubated with both cytoplasmic extract and nuclei or nuclear extracts of S-phase cells, >70% of adult cardiomyocyte nuclei underwent DNA synthesis. In conclusion, these results demonstrate that postmitotic ventricular myocyte nuclei are responsive to stimuli derived from S-phase cells and can thus bypass the cell cycle block. This cell-free system now makes it feasible to analyze the molecular requirements for the release of the cell cycle block and will help to engineer strategies for regenerative growth in cardiac muscle.


Key Words: cell cycle • cardiomyocyte • DNA synthesis




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
W.-H. Zimmermann, M. Didie, S. Doker, I. Melnychenko, H. Naito, C. Rogge, M. Tiburcy, and T. Eschenhagen
Heart muscle engineering: An update on cardiac muscle replacement therapy
Cardiovasc Res, August 1, 2006; 71(3): 419 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Salvatorelli, P. Menna, S. Cascegna, G. Liberi, A. M. Calafiore, L. Gianni, and G. Minotti
Paclitaxel and Docetaxel Stimulation of Doxorubicinol Formation in the Human Heart: Implications for Cardiotoxicity of Doxorubicin-Taxane Chemotherapies
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 424 - 433.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. C. Meckert, H. G. Rivello, C. Vigliano, P. Gonzalez, R. Favaloro, and R. Laguens
Endomitosis and polyploidization of myocardial cells in the periphery of human acute myocardial infarction
Cardiovasc Res, July 1, 2005; 67(1): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
F. B. Engel, M. Schebesta, M. T. Duong, G. Lu, S. Ren, J. B. Madwed, H. Jiang, Y. Wang, and M. T. Keating
p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes
Genes & Dev., May 15, 2005; 19(10): 1175 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Reffelmann and R. A. Kloner
Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure?
Cardiovasc Res, May 1, 2003; 58(2): 358 - 368.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Goldenthal and J. Marin-Garcia
Stem cells and cardiac disorders: an appraisal
Cardiovasc Res, May 1, 2003; 58(2): 369 - 377.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. B. Engel, L. Hauck, M. Boehm, E. G. Nabel, R. Dietz, and R. von Harsdorf
p21CIP1 Controls Proliferating Cell Nuclear Antigen Level in Adult Cardiomyocytes
Mol. Cell. Biol., January 15, 2003; 23(2): 555 - 565.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R. VON HARSDORF
Can cardiomyocytes divide?
Heart, November 1, 2001; 86(5): 481 - 482.
[Full Text] [PDF]